Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine and Oxaliplatin With or Without KN035 for Biliary Tract Cancer
NCT03478488Phase 3Completed
- Sponsor
- 3D Medicines Inc.
- Start
- Apr 2018
- Primary completion
- Sep 2024
- Modality
- Nanobodies (VHH), Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of envafolimab in biliary tract cancer (BTC), sponsored by 3D Medicines Inc.. Started Apr 2018; status: completed.
02
Drugs
envafolimab
03
Conditions
biliary tract cancer (BTC)
Beyond the preview
Go deeper on NCT03478488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03478488.